tiprankstipranks
Satellos Bioscience (MSLE)
NASDAQ:MSLE
US Market

Satellos Bioscience (MSLE) Financial Statements

32 Followers

Satellos Bioscience Financial Overview

Satellos Bioscience's market cap is currently $119.38M. The company's EPS TTM is $-1.9648; its P/E ratio is -1.76; Satellos Bioscience is scheduled to report earnings on May 15, 2026, and the estimated EPS forecast is $-0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ -5.09K$ -20.00K$ -8.82M$ -3.73M$ -165.69K
Operating Income$ -26.92M$ -27.81M$ -15.46M$ -8.43M$ -6.65M
EBITDA$ -26.92M$ -28.08M$ -15.71M$ -8.09M$ -4.60M
Net Income$ -25.31M$ -28.10M$ -15.89M$ -11.32M$ -15.51M
Balance Sheet
Cash & Short-Term Investments$ 27.66M$ 69.85M$ 39.59M$ 1.92M$ 4.87M
Total Assets$ 31.83M$ 73.02M$ 44.30M$ 6.20M$ 12.59M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -9.79M$ -57.66M$ -22.07M$ -1.92M$ -4.87M
Total Liabilities$ 4.10M$ 5.16M$ 3.62M$ 2.83M$ 2.10M
Stockholders' Equity$ 27.73M$ 67.86M$ 40.67M$ 3.37M$ 10.48M
Cash Flow
Free Cash Flow$ -24.02M$ -24.98M$ -14.52M$ -5.79M$ -5.04M
Operating Cash Flow$ -24.01M$ -24.98M$ -14.50M$ -5.78M$ -5.03M
Investing Cash Flow$ -9.58M$ 6.34M$ -17.54M$ -3.00K$ 1.74M
Financing Cash Flow$ 2.28M$ 53.48M$ 51.03M$ 2.77M$ 7.45M
Currency in USD

Satellos Bioscience Earnings and Revenue History

Satellos Bioscience Debt to Assets

Satellos Bioscience Cash Flow

Satellos Bioscience Forecast EPS vs Actual EPS